Omalizumab mitigates anaphylaxis during ultrarush honey bee venom immunotherapy in monoclonal mast cell activation syndrome

被引：35
作者：
da Silva, Elizabeth Nicole [1 ,2 ]
Randall, Katrina Louise [1 ,2 ]
机构：
[1] Canberra Hosp, Dept Immunol, Canberra, ACT, Australia
[2] Australian Natl Univ, Sch Med, Canberra, ACT, Australia
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 2013年 / 1卷 / 06期
关键词：
D O I：
10.1016/j.jaip.2013.07.004
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：687 / 688
页数：2
相关论文
共 11 条
[1]   Omalizumab-induced reductions in mast cell FcεRI expression and function [J].
Beck, LA ;
Marcotte, GV ;
MacGlashan, D ;
Togias, A ;
Saini, S .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 114 (03) :527-530
[2]   Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels [J].
Bonadonna, Patrizia ;
Perbellini, Omar ;
Passalacqua, Giovanni ;
Caruso, Beatrice ;
Colarossi, Sabrina ;
Dal Fior, Daniela ;
Castellani, Luca ;
Bonetto, Chiara ;
Frattini, Francesco ;
Dama, Annarita ;
Martinelli, Giovanni ;
Chilosi, Marco ;
Senna, Gianenrico ;
Pizzolo, Giovanni ;
Zanotti, Roberta .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (03) :680-686
[3]  
Elberink JNGO, 1997, J ALLERGY CLIN IMMUN, V99, P153, DOI 10.1016/S0091-6749(97)70314-2
[4]  
Galera C, 2009, J INVEST ALLERG CLIN, V19, P225
[5]  
Gomis VS, 2008, J INVEST ALLERG CLIN, V18, P225
[6]   High omalizumab dose controls recurrent reactions to venom immunotherapy in indolent systemic mastocytosis [J].
Kontou-Fili, K. .
ALLERGY, 2008, 63 (03) :376-378
[7]   Prolonged high-dose omalizumab is required to control reactions to venom immunotherapy in mastocytosis [J].
Kontou-Fili, K. ;
Filis, C. I. .
ALLERGY, 2009, 64 (09) :1384-1385
[8]   OMALIZUMAB MONOTHERAPY FOR BEE STING AND UNPROVOKED "ANAPHYLAXIS" IN A PATIENT WITH SYSTEMIC MASTOCYTOSIS AND UNDETECTABLE SPECIFIC IgE [J].
Kontou-Fili, Kalliopi ;
Filis, Christos I. ;
Voulgari, Christina ;
Panayiotidis, Panayiotis G. .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2010, 104 (06) :537-539
[9]   Diagnosis and management of hymenoptera venom allergy: British Society for Allergy and Clinical Immunology (BSACI) guidelines [J].
Krishna, M. T. ;
Ewan, P. W. ;
Diwakar, L. ;
Durham, S. R. ;
Frew, A. J. ;
Leech, S. C. ;
Nasser, S. M. .
CLINICAL AND EXPERIMENTAL ALLERGY, 2011, 41 (09) :1201-1220
[10]   Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: The importance of baseline serum tryptase [J].
Rueff, Franziska ;
Przybilla, Bernhard ;
Bilo, Maria Beatrice ;
Mueller, Ulrich ;
Scheipl, Fabian ;
Aberer, Werner ;
Birnbaum, Joelle ;
Bodzenta-Lukaszyk, Anna ;
Bonifazi, Floriano ;
Bucher, Christoph ;
Campi, Paolo ;
Darsow, Ulf ;
Egger, Cornelia ;
Haeberli, Gabrielle ;
Hawranek, Thomas ;
Kucharewicz, Iwona ;
Kuechenhoff, Helmut ;
Lang, Roland ;
Quercia, Oliviero ;
Reider, Norbert ;
Severino, Maurizio ;
Sticherling, Michael ;
Sturm, Gunter Johannes ;
Wuethrich, Brunello .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 126 (01) :105-111
12